Unexpected expression of mismatch repair protein is more commonly seen with pathogenic missense than with other mutations in Lynch syndrome
- 8 July 2020
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 103, 34-41
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (P30 CA016058)
- Pelotonia
- Ohio State University
- Comprehensive Cancer Center
- James Cancer Hospital and Solove Research Institute
This publication has 29 references indexed in Scilit:
- How reliable is immunohistochemical staining for DNA mismatch repair proteins performed after neoadjuvant chemoradiation?Human Pathology, 2014
- Template for Reporting Results of Biomarker Testing of Specimens From Patients With Carcinoma of the Colon and RectumArchives of Pathology & Laboratory Medicine, 2014
- Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistryFamilial Cancer, 2013
- ColoSeq Provides Comprehensive Lynch and Polyposis Syndrome Mutational Analysis Using Massively Parallel SequencingThe Journal of Molecular Diagnostics, 2012
- Accurate and exact CNV identification from targeted high-throughput sequence dataBMC Genomics, 2011
- Neoadjuvant Therapy Induces Loss of MSH6 Expression in Colorectal CarcinomaAmerican Journal of Surgical Pathology, 2010
- Feasibility of Screening for Lynch Syndrome Among Patients With Colorectal CancerJournal of Clinical Oncology, 2008
- Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 stainingThe Journal of Pathology, 2005
- Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)New England Journal of Medicine, 2005
- Mutations Associated with HNPCC Predisposition — Update of ICG‐HNPCC/INSiGHT Mutation DatabaseDisease Markers, 2004